| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Ontology engineering. | Nat Biotechnol | 2010 | 2.24 |
| 2 | GO PaD: the Gene Ontology Partition Database. | Nucleic Acids Res | 2006 | 1.98 |
| 3 | Genomic characterization of Wilms' tumor suppressor 1 targets in nephron progenitor cells during kidney development. | Development | 2010 | 1.21 |
| 4 | Targeting STAT5 in hematologic malignancies through inhibition of the bromodomain and extra-terminal (BET) bromodomain protein BRD2. | Mol Cancer Ther | 2014 | 1.09 |
| 5 | The STAT5 Inhibitor Pimozide Displays Efficacy in Models of Acute Myelogenous Leukemia Driven by FLT3 Mutations. | Genes Cancer | 2012 | 1.05 |
| 6 | Distinct roles of STAT3 and STAT5 in the pathogenesis and targeted therapy of breast cancer. | Mol Cell Endocrinol | 2013 | 1.04 |
| 7 | STAT signaling in the pathogenesis and treatment of myeloid malignancies. | JAKSTAT | 2012 | 0.92 |
| 8 | System-wide peripheral biomarker discovery using information theory. | Pac Symp Biocomput | 2008 | 0.81 |